Annual report [Section 13 and 15(d), not S-K Item 405]

Common Stock (Details Narrative)

v3.25.1
Common Stock (Details Narrative) - USD ($)
 12 Months Ended
Apr. 04, 2023
Jul. 01, 2020
Dec. 31, 2024
Dec. 31, 2023
Jun. 27, 2024
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Capital stock, shares authorized     101,000,000   155,000,000
Common stock, shares authorized     100,000,000 150,000,000 150,000,000
Preferred stock, shares authorized     1,000,000   5,000,000
Common stock, par value     $ 0.001 $ 0.001  
Common stock, shares, issued     10,174,000 10,174,000  
Common stock, shares, outstanding     10,174,000 10,174,000  
Proceeds from common stock     $ 4,000,000  
Warrants outstanding     11,000  
Warrant Liabilities [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Warrants outstanding     0 11,000  
Securities Purchase Agreement [Member] | Two Accredited Investors [Member] | Share-Based Payment Arrangement, Tranche One [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Total purchase price value, investments $ 2,000,000        
Securities Purchase Agreement [Member] | Two Accredited Investors [Member] | Share-Based Payment Arrangement, Tranche Two [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Total purchase price value, investments $ 2,000,000        
Securities Purchase Agreement [Member] | Common Stock [Member] | Two Accredited Investors [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Number of shares purchase 2,030,458        
Share price $ 1.97        
Total purchase price value, investments $ 4,000,000        
At-The-Market Offering Agreement [Member] | Maximum [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Proceeds from common stock   $ 10,000,000